Brief: Intra-Cellular Therapies Q1 net loss USD 44.1 million
May 4 (Reuters) - Intra-Cellular Therapies Q1 net income USD -44.1 million. * Q1 product revenue USD 95.3 million * Outlook FY product revenue USD 430-455 million
Recent news on Intra-Cellular Therapies
See all newsBrief: Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)